Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Termite tubing preventative for non-wood materials
Content reproduction apparatus and content processing method therefor
Identification of biomarkers in biological samples and methods of using same
Management of computer-file sharing between at least two devices
Routing of data including multimedia between electronic devices
Piperazinedione compounds
Electrophoresis display having touch screen and method for driving the touch screen
  Randomly Featured Patents
Contact type image sensor with more-unified construction
Bottle opener for disposable lighter
Power control device
Chemical processes for the manufacture of substituted benzofurans
Method of manufacturing a cranial shock absorption system
Systems and methods for diagnosing battery voltage mis-reporting
Convenient-used securing clamp
Metal value recovery from carbonaceous ores
Connector plug
Amine salts of tertiary amino acids